Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Cancers
|
May 18, 2019
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
Anthony P Conley, Wei-Lien Wang, John A Livingston, et al.
Sarcoma
|
June 23, 2020
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma
Amanda Parkes, Elizabeth Urquiola, Priya Bhosale, et al.
Cancers
|
May 11, 2024
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors
Ryan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
Vivek Subbiah, Sant P Chawla, Anthony P Conley, et al.
AJR. American Journal of Roentgenology
|
July 31, 2024
Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients
Koustav Pal, Ahmed Awad, Steven Yevich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 9, 2022
Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma
Andrew J Bishop, Behrang Amini, Heather Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
Cancer Medicine
|
September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma
Prapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
American Journal of Clinical Oncology
|
September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?
Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Cancers
|
May 18, 2019
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
Anthony P Conley, Wei-Lien Wang, John A Livingston, et al.
Sarcoma
|
June 23, 2020
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma
Amanda Parkes, Elizabeth Urquiola, Priya Bhosale, et al.
Cancers
|
May 11, 2024
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors
Ryan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
Vivek Subbiah, Sant P Chawla, Anthony P Conley, et al.
AJR. American Journal of Roentgenology
|
July 31, 2024
Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients
Koustav Pal, Ahmed Awad, Steven Yevich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 9, 2022
Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma
Andrew J Bishop, Behrang Amini, Heather Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
Cancer Medicine
|
September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma
Prapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
American Journal of Clinical Oncology
|
September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?
Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Page
of 8